DAIC

FEBRUARY 23, 2024

milla1cf Fri, 02/23/2024 - 11:54 February 23, 2024 — Cleerly , the company creating a new standard of care to aid in the diagnosis of heart disease, announced that its recently U.S. Sponsored by Cleerly and Presented at the American College of Cardiology Annual Scientific Meeting New Orleans LA 2023. 2023 Dec 12:jead339.

Ischemia 105

Ischemia Coronary Artery Disease Physiology Cardiovascular Imaging 105

DAIC

JUNE 18, 2024

The breakthrough designation, according to the Milpitas, CA-based technology company, is for an indication to improve coronary luminal diameter, restore hemodynamic modulation, and reduce plaque progression in patients with symptomatic ischemic heart disease due to discrete de novo native coronary artery lesions. of the U.S.

Coronary Artery Disease 105

Coronary Artery Disease Technology Stent Stents 105

DAIC

JANUARY 25, 2024

The companies will jointly support a series of educational forums among clinicians beginning later this year highlighting the significant new scientific breakthroughs that are radically transforming the traditional approach to heart disease prevention and prediction. In June 2023, the U.S.

Heart Attack 110

Heart Attack Heart attacks Technology Cardiovascular Disease 110

DAIC

JANUARY 3, 2024

Since its inception, HeartFlow has been committed to building a new standard of care for people at risk of heart disease. For over a decade, HeartFlow’s deep partnerships with more than 1,000 hospitals globally, including 80% of the top 50 heart hospitals in the U.S., REVEALPLAQUE Study, SCCT 2023. Data on file.

Coronary Artery Disease 59

Coronary Artery Disease Chest Pain Plaque Technology 59

Dr. Paddy Barrett

SEPTEMBER 5, 2023

Share Let’s first state our goal when we are in the business of ‘Heart Disease Prevention’: To delay the onset of coronary artery disease (atherosclerosis/plaque) that might rupture and cause a heart attack. And the less plaque you have, the lower the risk of a heart attack.

Plaque 52

Plaque Heart Attack Heart attacks Exercise 52

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

DAIC

FEBRUARY 8, 2024

million deaths attributable to stroke worldwide and about half of those were ischemic stroke, according to the most recent data in the 2024 Heart Disease and Stroke Statistics: A Report of U.S. and Global Data From the American Heart Association. In 2021, there were 7.44 In the U.S.,

Research 105

Research Strokes Stroke Heart Attack 105

Journal of Cardiovascular Pharmacology

NOVEMBER 26, 2023

This study enrolled 225 patients diagnosed with coronary heart disease and multivessel disease (MVD). A significantly higher proportion of patients in the ISR with non-target lesion progression (N-TLP) group exhibited lipid plaque formation compared to the ISR without N-TLP group (69.0% versus 39.8%, P < 0.001).

Atherosclerosis 40

Atherosclerosis Stent Stents Plaque 40

Heart 2023 Conference

APRIL 20, 2022

Stroke) A Danish study indicated that combining nitrates and PDE5 inhibitors isn't always a terrible idea for men with ischemic heart disease and erectile dysfunction. JACC: Asia) Lexaria Bioscience has announced that a CBD product beats a placebo in simulating acute pulmonary hypertension.

Pulmonary 52

Pulmonary Hypertension AFIB COVID-19 52

DAIC

FEBRUARY 29, 2024

24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Dr. Paddy Barrett

JULY 12, 2024

If you have high LDL cholesterol and are unsure what that means for your risk of heart disease, this article is for you. This 10-year phase shift in LDL cholesterol level rise is thought to explain why females tend to develop heart disease about ten years later than males. Heart attacks kill people.

Cholesterol 105

Cholesterol Heart Attack Heart attacks Blood Pressure 105

Dr. Smith's ECG Blog

FEBRUARY 6, 2025

There were no plaques or stenoses. See here: Narrow Complex Tachycardia at a Rate of 220 Below is a Practical Approach to Flecainide Dosing: Exclude contraindications such as structural heart disease; symptomatic bradycardia; 2nd-degree or high-degree AV block; QRS >120 msec.; Underlying Heart Disease?

Tachycardia 72

Tachycardia Arrhythmia Atrial Flutter Ablation 72